11
Views
18
CrossRef citations to date
0
Altmetric
Original Article

The in vivo interaction between flavone acetic acid and hyperthermia

, , &
Pages 779-789 | Received 21 Aug 1995, Accepted 23 May 1996, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Michael R. Horsman. (2016) Realistic biological approaches for improving thermoradiotherapy. International Journal of Hyperthermia 32:1, pages 14-22.
Read now
Ane B. Iversen, Morten Busk & Michael R. Horsman. (2013) Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy. Acta Oncologica 52:7, pages 1320-1326.
Read now
Michael R. Horsman. (2008) Angiogenesis and vascular targeting: Relevance for hyperthermia. International Journal of Hyperthermia 24:1, pages 57-65.
Read now
Tomas Breidahl, Flemming U. Nielsen, Hans Stødkilde-Jørgensen, Ross J. Maxwell & Michael R. Horsman. (2006) The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS. Acta Oncologica 45:3, pages 306-316.
Read now
Michael R. Horsman. (2006) Tissue physiology and the response to heat. International Journal of Hyperthermia 22:3, pages 197-203.
Read now
Michael R. Horsman, Rumi Murata, Jens Overgaard. (2001) Improving Local Tumor Control by Combining Vascular Targeting Drugs, Mild Hyperthermia and Radiation. Acta Oncologica 40:4, pages 497-503.
Read now

Articles from other publishers (10)

A.L. Oei, H.P. Kok, S.B. Oei, M.R. Horsman, L.J.A. Stalpers, N.A.P. Franken & J. Crezee. (2020) Molecular and biological rationale of hyperthermia as radio- and chemosensitizer. Advanced Drug Delivery Reviews 163-164, pages 84-97.
Crossref
Michael R. Horsman & Dietmar W. Siemann. (2006) Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies. Cancer Research 66:24, pages 11520-11539.
Crossref
Gian Franco Baronzio, Vincenzo Cerreta, Attilio Baronzio, Isabel Freitas, Marco Mapelli & Alberto Gramaglia. 2006. Hyperthermia in Cancer Treatment: A Primer. Hyperthermia in Cancer Treatment: A Primer 128 155 .
Michael R Horsman & Rumi Murata. (2002) Combination of vascular targeting agents with thermal or radiation therapy. International Journal of Radiation Oncology*Biology*Physics 54:5, pages 1518-1523.
Crossref
Michael Kragh, Bjørn Quistorff, Michael R. Horsman & Paul E.G. Kristjansen. (2002) Acute Effects of Vascular Modifying Agents in Solid Tumors Assessed by Noninvasive Laser Doppler Flowmetry and Near Infrared Spectroscopy. Neoplasia 4:3, pages 263-267.
Crossref
Rumi Murata, Dietmar W. Siemann, Jens Overgaard & Michael R. Horsman. (2001) Improved Tumor Response by Combining Radiation and the Vascular-Damaging Drug 5,6-Dimethylxanthenone-4-acetic Acid. Radiation Research 156:5, pages 503-509.
Crossref
Rumi Murata, Jens Overgaard & Michael R Horsman. (2001) Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotheraphy. International Journal of Radiation Oncology*Biology*Physics 51:4, pages 1018-1024.
Crossref
Rumi Murata, Dietmar W. Siemann, Jens Overgaard & Michael R. Horsman. (2001) Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors. Radiotherapy and Oncology 60:2, pages 155-161.
Crossref
M. R. Horsman, R. Murata, T. Breidahl, F. U. Nielsen, R. J. Maxwell, H. Stødkiled-Jørgensen & J. Overgaard.. 2000. Angiogenesis. Angiogenesis 311 323 .
Michael R Horsman, Eva Ehrnrooth, Morten Ladekarl & Jens Overgaard. (1998) The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors. International Journal of Radiation Oncology*Biology*Physics 42:4, pages 895-898.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.